Business
117
|
87
Glenmark hits 52-week high on US nod for asthma generic
hit a fresh 52-week high on Monday after the company received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treatingsaid it would immediately commence distribution of the asthma drug in the US market.Glenmark shares however pared gains in late trade to trade marginally lower in late trade, down 0.3 per cent at 407.50.Earlier in the session, Glen
